+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Hirudin as conjunctive therapy in patients with thrombolysis for acute myocardial infarction produced stable prolongation of ACT and APTT



Hirudin as conjunctive therapy in patients with thrombolysis for acute myocardial infarction produced stable prolongation of ACT and APTT



Circulation 88(4 Part 2): I201




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 031702758

Download citation: RISBibTeXText


Related references

Hirudin as adjunctive therapy in patients with thrombolysis for acute myocardial infarction produced stable prolongation of ACT and APTT. European Heart Journal 14(ABSTR Suppl. ): 179, 1993

Thrombin generation during thrombolysis with rt-PA and conjunctive therapy with r-hirudin in patients with acute myocardial infarction. Annals of Hematology 73(Suppl. 1): S65, 1996

Frequency of "optimal anticoagulation" for acute myocardial infarction after thrombolysis with front-loaded recombinant tissue-type plasminogen activator and conjunctive therapy with recombinant hirudin (HBW 023). ALKK Study Group. American Journal of Cardiology 76(14): 997, 1995

Recombinant hirudin (HBW 023) produces stable anticoagulation unaffected by circadian variation in patients with thrombolysis for acute myocardial infarction. European Heart Journal 17(12): 1836-1840, 1996

Plasma hirudin and aPTT levels in acute patients of the GUSTO-2A trial compared with hirudin levels and aPTT in volunteers with stable coronary disease. European Heart Journal 16(ABSTR Suppl. ): 177, 1995

Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction. Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25). American Heart Journal 149(2): 217-226, 2005

Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial. Circulation 83(2): 448-459, 1991

Non-invasive detection of early infarct vessel patency by resolution of ST-segment elevation in patients with thrombolysis for acute myocardial infarction; results of the angiographic substudy of the Hirudin for Improvement of Thrombolysis (HIT)-4 trial. European Heart Journal 22(9): 769-775, 2001

Recombinant hirudin and front-loaded alteplase in acute myocardial infarction: final results of a pilot study. HIT-I (hirudin for the improvement of thrombolysis). European Heart Journal 16 Suppl D: 22-27, 1995

Recombinant hirudin achieves optimal anticoagulation in patients with thrombolysis for acute myocardial infarction. European Heart Journal 15(ABSTR Suppl. ): 469, 1994

Hirudin for the improvement of thrombolysis with streptokinase in patients with acute myocardial infarction Results of the HIT-4 study. Circulation 96(8 Suppl. ): I205, 10/21/97, 1997

Hirudin for the improvement of thrombolysis with streptokinase in patients with acute myocardial infarction Results of the HIT-4 angiographic substudy. European Heart Journal 18(ABSTR Suppl. ): 454, 1997

Hirudin in acute myocardial infarction. Safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A Trial. Circulation 90(4): 1624-1630, 1994

Initial experience with hirudin and streptokinase in acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 6 trial. American Journal of Cardiology 75(1): 7-13, 1995